CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a new drug, 177Lu-TLX250, which delivers radiation directly to kidney cancer cells. It is for adults with advanced clear cell renal cell carcinoma that has come back or spread. The trial compares two different doses of the drug to standard single-drug therapy to …
Matched conditions: CCRCC
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that cannot be removed by surgery. About 30 participants who have tried other treatments or cannot take them will receive the drug to see if it is safe and what dose works best…
Matched conditions: CCRCC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated May 11, 2026 20:41 UTC